WaveMan
WaveMan · Company
ESTA · Establishment Labs Holdings Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

ESTA Establishment Labs (ESTA) Insider Trading, Ownership & Congress Trades

Medical Devices · Orthopedic, prosthetic & surgical appliances & supplies · CIK 0001688757
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
124
13F, latest reported quarter

What the filings say about ESTA

Insiders, 180 days
-$25.9M net sold
4 sellers · 0% of sales under a 10b5-1 plan

Establishment Labs insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, ESTABLISHMENT LABS HOLDINGS INC. insiders sold a net $25.9M of stock across 69 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
JW Partners, LP
SELL
2026-05-28 SEC
65,100
$4.7M
-6.9%
Context
  • 4 earlier Form 4 trades (code P or S) here by this insider (2 buys, 2 sales), the last on May 27, 2026.
  • +3.3% median (+3.3% mean) 90-day return after 2 previous buys.
  • The trade is 2.3% of the 2,890,582 shares held after it.
  • 3 other insiders sold within 30 days.
  • 124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider JW Partners, LP sold about $4.7M of ESTA on May 28, 2026; 3 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
JW Partners, LP
SELL
2026-05-28 SECtraded 2026-05-27
113
$8.2K
-6.9%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (2 buys, 1 sale), the last on May 26, 2026.
  • +3.3% median (+3.3% mean) 90-day return after 2 previous buys.
  • The trade is 0.0% of the 2,955,682 shares held after it.
  • 3 other insiders sold within 30 days.
  • 124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider JW Partners, LP sold about $8.2K of ESTA on May 27, 2026; 3 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
JW Partners, LP
SELL
2026-05-28 SECtraded 2026-05-26
25,320
$1.9M
-6.9%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Mar 14, 2022.
  • +3.3% median (+3.3% mean) 90-day return after 2 previous buys.
  • The trade is 0.9% of the 2,955,795 shares held after it.
  • 3 other insiders sold within 30 days.
  • 124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider JW Partners, LP sold about $1.9M of ESTA on May 26, 2026; 3 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
JW GP, LLC
SELL
2026-05-22 SECtraded 2026-05-21
16,999
$1.2M
-9.4%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (1 buy, 2 sales), the last on May 20, 2026.
  • The trade is 0.6% of the 2,981,115 shares held after it.
  • 3 other insiders sold within 30 days.
  • 124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider JW GP, LLC sold about $1.2M of ESTA on May 21, 2026; 3 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
JW GP, LLC
SELL
2026-05-22 SECtraded 2026-05-20
3,580
$252.6K
-9.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (1 buy, 1 sale), the last on Dec 4, 2024.
  • The trade is 0.1% of the 2,998,114 shares held after it.
  • 3 other insiders sold within 30 days.
  • 124 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider JW GP, LLC sold about $252.6K of ESTA on May 20, 2026; 3 other insiders sold within 30 days and 124 funds added in the latest 13F quarter.
69 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 64 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$25.9M over 180 days
-$6.0M of it by a 10%+ holder
below 94% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
124 funds bought in last quarter
more than 69% of Medical Devices
Revenue
+27.1% year over year
more than 78% of Medical Devices
Margin
-24.2% net margin
below 56% of Medical Devices
Buybacks
no share repurchases reported
Short interest
20.4% of the float short (float per yahoo 2026-10-26) · 12.1 days to cover · settled 2026-09-30
more than 94% of Medical Devices
What changed in the last 30 days
Oct 28Insider selling stopped: no sales in 90 days after 10 in the prior 90
Why it matters
The absence is the signal: 10 sales in one 90-day window and none in the next is a change of behaviour, not a filing.

Watch ESTA

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+32.6%12M
-4%+29%+61%+93%2025-102025-122026-022026-042026-062026-082026-10 2026-05-06 · Chacon Quiros Juan Jose sold $7.0M2026-05-28 · JW Partners, LP sold $4.7M2026-05-06 · JW Asset Management, LLC sold $4.5M2026-05-01 · Chacon Quiros Juan Jose sold $2.9M2026-04-14 · Chacon Quiros Juan Jose sold $2.4M2026-04-23 · Chacon Quiros Juan Jose sold $2.0M2026-03-23 · Chacon Quiros Juan Jose sold $1.9M2026-05-26 · JW Partners, LP sold $1.9M2026-05-01 · Chacon Quiros Juan Jose sold $1.8M2026-04-24 · Chacon Quiros Juan Jose sold $1.5M2026-05-21 · JW GP, LLC sold $1.2M2026-05-06 · Chacon Quiros Juan Jose sold $897.5K2025-11-10 · JW Opportunities Fund, LLC sold $737.8K2026-05-04 · Chacon Quiros Juan Jose sold $539.2K2026-04-24 · Chacon Quiros Juan Jose sold $500.5K2025-11-06 · Wild Jason G. sold $493.4K2026-04-23 · Chacon Quiros Juan Jose sold $447.3K2026-04-23 · Chacon Quiros Juan Jose sold $320.0K2026-05-20 · JW GP, LLC sold $252.6K2026-03-25 · Chacon Quiros Juan Jose sold $214.8K2025-11-07 · JW Asset Management, LLC sold $162.7K2026-03-23 · Chacon Quiros Juan Jose sold $94.7K2026-04-27 · Chacon Quiros Juan Jose sold $67.0K2026-04-27 · Chacon Quiros Juan Jose sold $66.4K2026-03-23 · Chacon Quiros Juan Jose sold $48.6K2026-04-23 · Chacon Quiros Juan Jose sold $26.9K2026-03-23 · Chacon Quiros Juan Jose sold $12.6K2026-04-27 · Chacon Quiros Juan Jose sold $11.1K2026-05-27 · JW Partners, LP sold $8.2K2026-05-04 · Chacon Quiros Juan Jose sold $7.1K
Insider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns ESTA: institutional holders (13F)

13F holdings, latest reported quarter
JW Asset Management, LLC
2,692,856 sh
$231.1M
RTW INVESTMENTS, LP
2,655,695 sh
$227.9M
BlackRock, Inc.
1,582,005 sh
$135.8M
BROWN ADVISORY INC
1,313,148 sh
$112.7M
FINDELL CAPITAL MANAGEMENT LLC
1,096,000 sh
$94.0M

Congress trades in ESTA

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

ESTA planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

ESTA mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Dunham Small Cap Growth Fund
$1.2M position · as of 2026-07-31
1.6%
Invesco Dorsey Wright Healthcare Momentum ETF
$3.6M position · as of 2026-07-31
1.5%
Nuveen Small Cap Growth Opportunities Fund
$2.3M position · as of 2026-07-31
0.9%
SmallCap Growth Fund I
$20.1M position · as of 2026-07-31
0.8%
Nuveen Small Cap Select Fund
$3.3M position · as of 2026-07-31
0.8%
Clearwater Select Equity Fund
$3.7M position · as of 2026-06-30
0.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Filippo "Peter" Caldini
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$2.6M
$7.3M
$1.1M
+67%
+5%
2023
$2.4M
$304.1K
$982.6K
-6%
+6%
2022
$2.6M
$5.6M
$1.4M
+137%
+0%
2021
$2.3M
$5.9M
$3.4M
+144%
+25%
2020
$598.2K
$2.7M
$474.5K
+36%
+30%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $25.9M sold by insiders over 180 days, 124 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
PENBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXOMIRMD

ESTA financials

Revenue growth
+27.1%
XBRL, annual
Net margin
-24.2%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$245.8M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-15.8%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
-$41.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
12.57x
long-term 2026-06-30 plus current 2025-09-30 (9 months older than the period end); equity 2026-06-30
Cash flow to debt
-0.12x
TTM operating cash flow over long-term 2026-06-30 plus current 2025-09-30 (9 months older than the period end)
Return on equity
-175.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-11.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-7.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
$2.2B
market value at close 2026-10-26 on 2026-08-06 shares, plus long-term 2026-06-30 plus current 2025-09-30 (9 months older than the period end), minus cash 2026-06-30
FCF yield
-2.1%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$211.1M$166.0M$165.2M$161.7M
Gross profit$146.3M$109.5M$107.0M$106.6M
Operating income-$39.0M-$50.0M-$65.0M-$39.7M
Net income-$51.1M-$84.6M-$78.5M-$75.2M
EPS (diluted)-1.72-3.00-3.07-3.08
Operating cash flow-$50.9M-$58.5M-$88.5M-$52.2M
Cash$75.6M$90.3M$40.0M$66.4M
Long-term debt$247.5M$219.6M$188.7M$175.5M
SEC XBRL, fiscal years, as known on 2026-10-28

ESTA Stock Sonar score 6/7 axes

Find similar shapesCompare

ESTA ranks highest on growth (78th percentile) and institutional and government (69th), and lowest on insider conviction (3rd), among Medical Devices peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
43
Inputs
  • Return on equity-175.3% · 16 pct, sector of 183
  • Return on assets-11.4% · 55 pct, sector of 214
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-7.0% · 59 pct, sector of 188
Financial health
25
Inputs
  • Debt to equity12.57x · 1 pct, sector of 159
  • Cash flow to debt-0.12x · 50 pct, sector of 150
Growth
78
Inputs
  • Revenue growth, YoY+27.1% · 78 pct, sector of 219
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
3
Inputs
  • Net Form 4 buying (codes P and S), 180d-$25.9M · 6 pct, sector of 140
  • Insider buyers, 180d0 · 0 pct, sector of 142
Institutional and government
69
Inputs
  • Funds adding, latest quarter124 · 69 pct, sector of 191
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
51
Inputs
  • Short interest, % of float+20.4% · 3 pct, sector of 240
  • Recalls per $1B revenue, 3y0.00 per $1B · 100 pct, sector of 116
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+10.5% · 51 pct, sector of 198
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

ESTA filings, in plain words

Are Establishment Labs insiders buying or selling ESTA?

In the 180 days to 2026-10-28, Establishment Labs insiders were net sellers, a net $25.9M across purchases and sales reported on Form 4, by 4 sellers.

Read the full summary

In the 180 days to 2026-10-28, Establishment Labs insiders were net sellers of ESTA, a net $25.9M across purchases and sales reported on Form 4 by 4 sellers. None of the 12 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies